13F filer · CIK 1458461
Healthcare Value Capital, LLC
Woodcliff Lake, NJ · filing since Q2 2013 · last filing Nov 15, 2021
Reported value
$50.7M
+$467.0K vs prior
Positions
25
New / sold out
5 / 3
Added / reduced
5 / 5
Turnover
17.0%
buys $11.5M · sells $8.6M
Top-10 weight
63.2%
Biggest buys vs Q2 2021
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | ALKERMES PLCPUT | +100,000 | – | +$3.1M |
| New | PFIZER INCPUT | +50,000 | – | +$2.2M |
| Added | PROSHARES TRCALL | +100,000 | +200.0% | +$1.8M |
| New | PROSHARES TR IICALL | +50,000 | – | +$1.2M |
| New | VERTEX PHARMACEUTICALS INC | +5,000 | – | +$907.0K |
| Added | PROSHARES TRCALL | +100,000 | +100.0% | +$863.0K |
| Added | AMRYT PHARMA PLC | +50,000 | +25.0% | +$604.6K |
| Added | TYME TECHNOLOGIES INC | +500,000 | +33.3% | +$515.0K |
| New | DURECT CORP | +250,000 | – | +$320.0K |
| Added | GAMIDA CELL LTD | +25,000 | +33.3% | +$98.0K |
Biggest sells vs Q2 2021
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | COLLEGIUM PHARMACEUTICAL INC | -100,000 | -100.0% | $-2.4M |
| Sold out | MIMEDX GROUP INC | -125,000 | -100.0% | $-1.6M |
| Reduced | ALKERMES PLC | -50,000 | -33.3% | $-1.5M |
| Reduced | PFIZER INC | -25,000 | -25.0% | $-1.1M |
| Reduced | GILEAD SCIENCES INC | -15,000 | -20.0% | $-1.0M |
| Sold out | IRONWOOD PHARMACEUTICALS INCCALL | -50,000 | -100.0% | $-644.0K |
| Reduced | PROSHARES TR IICALL | -12,500 | -50.0% | $-285.0K |
| Reduced | VYNE THERAPEUTICS INC | -50,000 | -11.1% | $-69.5K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2021
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | GILEAD SCIENCES INCCOM | 60,000 | $4.2M | 8.27% |
| 2 | GLAXOSMITHKLINE PLCSPONSORED ADR | 100,000 | $3.8M | 7.54% |
| 3 | PFIZER INCCOM | 75,000 | $3.2M | 6.37% |
| 4 | ALKERMES PLCSHS | 100,000 | $3.1M | 6.09% |
| 4 | ALKERMES PLCPUTSHS | 100,000 | $3.1M | 6.09% |
| 6 | AMRYT PHARMA PLCSPONSORED ADS | 250,000 | $3.0M | 5.97% |
| 7 | MERCK & CO INCCOM | 40,000 | $3.0M | 5.93% |
| 8 | ASTRAZENECA PLCSPONSORED ADR | 50,000 | $3.0M | 5.93% |
| 9 | BRISTOL-MYERS SQUIBB COCOM | 50,000 | $3.0M | 5.84% |
| 10 | PROSHARES TRCALLULTRAPRO SHORT S | 150,000 | $2.6M | 5.19% |
15 more rows. Subscribe for $29/month to see every row, download the data and use the API.